CLOV has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CLOV has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-05-26), Clover Health Investments's share price is $1.00. Clover Health Investments does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.
The historical rank and industry rank for Clover Health Investments's Price-to-Owner-Earnings or its related term are showing as below:
As of today (2024-05-26), Clover Health Investments's share price is $1.00. Clover Health Investments's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.34. Therefore, Clover Health Investments's PE Ratio for today is At Loss.
As of today (2024-05-26), Clover Health Investments's share price is $1.00. Clover Health Investments's EPS without NRI for the trailing twelve months (TTM) ended in was $-0.29. Therefore, Clover Health Investments's PE Ratio without NRI for today is At Loss.
The historical data trend for Clover Health Investments's Price-to-Owner-Earnings can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clover Health Investments Annual Data | |||||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | ||||||
Price-to-Owner-Earnings | - | - | - | - | - |
Clover Health Investments Quarterly Data | ||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Price-to-Owner-Earnings | Get a 7-Day Free Trial | - | - | - | - | - |
For the Healthcare Plans subindustry, Clover Health Investments's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Plans industry and Healthcare sector, Clover Health Investments's Price-to-Owner-Earnings distribution charts can be found below:
* The bar in red indicates where Clover Health Investments's Price-to-Owner-Earnings falls into.
In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:
"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."
Clover Health Investments's Price-to-Owner-Earnings for today is calculated as
Price-to-Owner-Earnings | = | Share Price | / | Owner Earnings per Share (TTM) |
= | 1.00 | / | 0.00 | |
= |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clover Health Investments (NAS:CLOV) Price-to-Owner-Earnings Explanation
For how to get Owner Earnings per Share (TTM), please click.
Thank you for viewing the detailed overview of Clover Health Investments's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.
Karen Soares | officer: General Counsel & Secretary | 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067 |
Clover Health Investments, Corp. /de | officer: Chief Technology Officer | 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067 |
Anna U Loengard | director | C/O CLOVER HEALTH INVESTMENTS, CORP., 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067 |
Andrew Toy | director, officer: Chief Executive Officer | C/O CLOVER HEALTH INVESTMENTS, CORP., 725 COOL SPRINGS BLVD., SUITE 320, FRANKLIN TN 37067 |
Scott J. Leffler | officer: Chief Financial Officer | C/O CLOVER HEALTH INVESTMENTS, CORP., 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067 |
Brady Patrick Priest | officer: CEO of Home Care | C/O CLOVER HEALTH INVESTMENTS, CORP., FRANKLIN TN 37067 |
Demetrios L. Kouzoukas | director | C/O CLOVER HEALTH INVESTMENTS, CORP., 725 COOL SPRINGS BLVD., SUITE 320, FRANKLIN FL 37067 |
Aric R Sharp | officer: CEO of Value-Based Care | C/O CLOVER HEALTH INVESTMENTS, CORP., 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067 |
Wai Conrad | officer: Chief Technology Officer | 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067 |
Joseph Richards Martin | officer: General Counsel | C/O LOUISIANA-PACIFIC CORPORATION, 414 UNION STREET, SUITE 2000, NASHVILLE TN 37219 |
Vivek Garipalli | director, 10 percent owner, officer: Executive Chairperson | C/O CLOVER HEALTH INVESTMENTS, CORP., 725 COOL SPRINGS BLVD., SUITE 320, FRANKLIN TN 37067 |
Carladenise Armbrister Edwards | director | C/O CLOVER HEALTH INVESTMENTS, CORP., 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067 |
Chelsea Clinton | director | C/O IAC 555 W 18TH STREET, NEW YORK NY 10011 |
Jamie L. Reynoso | officer: CEO of Medicare Advantage | C/O CLOVER HEALTH INVESTMENTS, CORP., 725 COOL SPRINGS BLVD., SUITE 320, FRANKLIN TN 37067 |
Chamath Palihapitiya | 10 percent owner, other: See Remarks | THE SOCIAL-CAPITAL PARTNERSHIP, L.L.C., 506 SANTA CRUZ AVENUE, SUITE 300, MENLO PARK CA 94025 |
From GuruFocus
By Marketwired • 09-22-2023
By Stock market mentor Stock market mentor • 01-04-2023
By Value_Insider Value_Insider • 11-03-2022
By PRNewswire • 11-14-2023
By PurpleRose PurpleRose • 07-26-2022
By sperokesalga sperokesalga • 05-04-2023
By Value_Insider Value_Insider • 11-30-2022
By sperokesalga sperokesalga • 04-24-2023
By Marketwired • 10-12-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.